Katya Gozias is a seasoned international investigative, business intelligence and risk mitigation professional with over 16 years of experience advising law firms and multinational corporations. She expertly consults on problems involving integrity and reputational risks and has led multi-disciplinary teams on investigations ranging from internal fraud to complex multi-jurisdictional asset searches.
Ms. Gozias has unique expertise in the emerging area of blockchain applications. She works with blockchain companies to develop a roadmap and framework for the addition of fully operable blockchain technology solutions for enterprise clients, to include configuration for KYC, cyber security, anti-fraud, and supply chain tracking.
She has also conducted AML reviews for money service businesses, payment processors, credit unions, and insurance companies, as well as advised on due diligence and compliance with FinCen guidelines. Ms. Gozias has broad experience designing rigorous compliance programs, policies and procedures, uncovering gaps, and ameliorating breaches of regulations. She has crafted, reviewed, and implemented U.S. Foreign Corrupt Practices Act (FCPA) programs and assisted with bank monitorships and lookback investigations.
Before joining Guidepost, Ms. Gozias was managing director at an international consulting company, and prior to that worked as a senior consultant in corporate investigations at a global risk consultancy. Ms. Gozias has been a speaker or moderator at various industry associations and has authored white papers and articles ranging from AML compliance, anti-bribery, and corruption to best practices for conducting interviews in remote investigations.
In addition to her Juris Doctorate, Ms. Gozias earned a certificate in blockchain technologies from the Massachusetts Institute of Technology. She speaks fluent Russian, intermediate Japanese, and basic Mandarin and Spanish.
Did you know?
Before law school, Katya worked at a University of Texas med school pathology lab. She helped sequence the genome for a pathogen that causes Lyme disease.
